Skip to main content

Ambrx Biopharma, Inc.

AMAMDelisted Mar 7, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001990550

Ambrx Biopharma, Inc. was delisted on Mar 7, 2024; its insiders filed their last Form 4 on Mar 7, 2024; 68 institutions reported holding it in 13F filings for Q4 2023, worth $912.7M in total; no superinvestor held it.

13F holders, Q3 2023

Institutional positions in Ambrx Biopharma, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
44
+3 vs. Q2 2023
Shares held
49.4M
+1.50M (+3.1%) vs. Q2 2023
Total value
$568.3M
−$220.5M (−28.0%) vs. Q2 2023
New holders
16
17 more added
Sold out
13
7 more reduced

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AMAM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 44 institutions
Q1 2021: 0 institutionsQ2 2021: 20 institutionsQ3 2021: 15 institutionsQ4 2021: 16 institutionsQ1 2022: 14 institutionsQ2 2022: 14 institutionsQ3 2022: 16 institutionsQ4 2022: 18 institutionsQ1 2023: 30 institutionsQ2 2023: 42 institutionsQ3 2023: 44 institutionsQ4 2023: 68 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2023: $568.3M
Q1 2021: $0Q2 2021: $266.2MQ3 2021: $165.3MQ4 2021: $152.0MQ1 2022: $70.6MQ2 2022: $45.4MQ3 2022: $18.0MQ4 2022: $40.7MQ1 2023: $330.7MQ2 2023: $788.8MQ3 2023: $568.3MQ4 2023: $912.7MQ1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding AMAM and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 202368$912.7M
Q3 202344$568.3M
Q2 202342$788.8M
Q1 202330$330.7M
Q4 202218$40.7M
Q3 202216$18.0M
Q2 202214$45.4M
Q1 202214$70.6M
Q4 202116$152.0M
Q3 202115$165.3M
Q2 202120$266.2M
Q1 20210$0

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding Ambrx Biopharma, Inc.; share changes are against Q2 2023.

Institutions holding AMAM in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Tower Research Capital LLC (TRC)235$2.70K0.00%+235New
Bank of America Corp500$5.75K0.00%−58−10.4%Reduced
US Bancorp1,018$11.7K0.00%00.0%Unchanged
Legal & General Group Plc1,381$15.9K0.00%+1,381New
Group One Trading, L.P.2,155$24.8K0.00%+2,155New
Cutler Group LP2,800$32.0K0.01%+1,000+55.6%Added
UBS Group AG5,574$64.1K0.00%+5,574New
Royal Bank of Canada6,500$75.0K0.00%+6,500New
Virtus ETF Advisers LLC6,793$78.1K0.05%−675−9.0%Reduced
Squarepoint Ops LLC22,132$254.5K0.00%+5,652+34.3%Added
Morgan Stanley24,571$282.6K0.00%+21,501+700.4%Added
Innovis Asset Management LLC31,137$358.1K0.14%+14,311+85.1%Added
HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)31,735$365.0K0.01%+31,735New
Apis Capital Advisors, LLC34,000$391.0K0.51%00.0%Unchanged
Alps Advisors Inc45,531$523.6K0.00%+4,933+12.2%Added
Alliancebernstein L.P.47,296$543.9K0.00%+47,296New
Bank of New York Mellon Corp47,433$545.5K0.00%+47,433New
Geode Capital Management, LLC50,140$576.6K0.00%+10,702+27.1%Added
State Street Corp50,400$579.6K0.00%+50,400New
Manufacturers Life Insurance Company, The59,282$681.7K0.00%+85+0.1%Added
Simplex Trading, LLC68,551$788.0K0.03%+61,917+933.3%Added
Monashee Investment Management LLC70,000$805.0K0.34%+70,000New
TD Asset Management Inc110,456$1.27M0.00%+46,728+73.3%Added
Logos Global Management LP115,000$1.32M0.19%+115,000New
First Manhattan Co135,003$1.55M0.01%00.0%Unchanged
Parkman Healthcare Partners LLC150,000$1.73M0.32%+150,000New
Nwi Management LP160,935$1.85M0.32%+160,935New
HighVista Strategies LLC193,701$2.23M1.03%+40,270+26.2%Added
Macquarie Group Ltd250,000$2.88M0.00%+250,000New
Ally Bridge Group (NY) LLC281,089$3.23M3.79%+281,089New
Millennium Management LLC464,633$5.34M0.01%+178,917+62.6%Added
Holocene Advisors, LP486,562$5.60M0.02%−427,192−46.8%Reduced
ExodusPoint Capital Management, LP493,393$5.67M0.07%+15,835+3.3%Added
Ghost Tree Capital, LLC525,000$6.04M2.92%+286,775+120.4%Added
Citadel Advisors LLC768,825$8.84M0.01%+41,803+5.7%Added
Price T Rowe Associates Inc821,564$9.45M0.00%−107,753−11.6%Reduced
FMR LLC1,761,058$20.3M0.00%−449,560−20.3%Reduced
VR Adviser, LLC2,070,000$23.8M2.51%−414,960−16.7%Reduced
Federated Hermes, Inc.2,395,867$27.6M0.07%+2,395,867New
Paradigm Biocapital Advisors LP3,488,596$40.1M2.74%+1,838,097+111.4%Added
Commodore Capital LP3,518,556$40.5M4.73%+343,556+10.8%Added
D. E. Shaw & Co., Inc.4,004,513$46.1M0.08%−11,395−0.3%Reduced
Cormorant Asset Management, LP9,923,689$114.1M6.66%+307,534+3.2%Added
Darwin Global Management, Ltd.16,688,636$191.9M67.54%00.0%Unchanged
Farallon Capital Management, L.L.C.0$00.00%−2,269,000−100.0%Sold out
Artal Group S.A.0$00.00%−702,291−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−349,938−100.0%Sold out
JPMorgan Chase & Co0$00.00%−157,858−100.0%Sold out
Moore Capital Management, LP0$00.00%−144,400−100.0%Sold out
Silverarc Capital Management, LLC0$00.00%−100,000−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−98,600−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−51,290−100.0%Sold out
Jane Street Group, LLC0$00.00%−17,538−100.0%Sold out
Belvedere Trading LLC0$00.00%−13,872−100.0%Sold out
QP Wealth Management, LLC0$00.00%−12,670−100.0%Sold out
Exchange Traded Concepts, LLC0$00.00%−9,830−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−400−100.0%Sold out
BerganKDV Wealth Management, LLC––––Not filed